Why does training clinical scientists for translational research take substantial time and funding?

The training of clinical scientists for translational medicine is a lengthy and expensive process primarily due to the increasing complexity of modern biomedical research. As the gap between laboratory discovery and clinical application has widened, there is a critical need for specialized scientists who can act as facilitators to bridge this divide.1

This training requires significant investment because these professionals must navigate an increasingly sophisticated biotechnology landscape. They are tasked with managing complex therapeutic agents—such as those involving genetic modification or cellular substances—which often operate through distinct, poorly understood mechanisms that are difficult to standardize. Furthermore, translational studies frequently demand interinstitutional collaboration and the participation of multiple experts, requiring a skill set that transcends traditional, fragmented disciplinary boundaries. Because current academic models often reward individual achievement rather than the collaborative, goal-oriented approach necessary for translational science, substantial incentives and resources are required to develop and retain these essential experts.1